These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The clinical role of prostate-specific membrane antigen (PSMA). Chang SS; Heston WD Urol Oncol; 2002; 7(1):7-12. PubMed ID: 12474535 [TBL] [Abstract][Full Text] [Related]
10. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563 [TBL] [Abstract][Full Text] [Related]
11. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer. Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734 [TBL] [Abstract][Full Text] [Related]
12. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
13. The utility of monoclonal antibodies in the imaging of prostate cancer. Yao D; Trabulsi EJ; Kostakoglu L; Vallabhajosula S; Joyce MA; Nanus DM; Milowsky M; Liu H; Goldsmith SJ Semin Urol Oncol; 2002 Aug; 20(3):211-8. PubMed ID: 12215974 [TBL] [Abstract][Full Text] [Related]
14. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma. Jia L; Jiang Y; Michael CW Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085 [TBL] [Abstract][Full Text] [Related]
15. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Murphy GP; Elgamal AA; Su SL; Bostwick DG; Holmes EH Cancer; 1998 Dec; 83(11):2259-69. PubMed ID: 9840525 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA). Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Gong MC; Chang SS; Sadelain M; Bander NH; Heston WD Cancer Metastasis Rev; 1999; 18(4):483-90. PubMed ID: 10855791 [TBL] [Abstract][Full Text] [Related]
18. Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer. Wolf P; Freudenberg N; Bühler P; Alt K; Schultze-Seemann W; Wetterauer U; Elsässer-Beile U Prostate; 2010 Apr; 70(5):562-9. PubMed ID: 19938014 [TBL] [Abstract][Full Text] [Related]
20. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]